MANKIND PHARMA LIMITED (MANKIND) financials — quarterly results, P&L, cash flow, balance sheet, shareholding
Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and several consumer healthcare products.[1]
Mankind Pharma Limited
MANKIND
ROE13.8%
ROCE13.7%
Stock P/E48.3
Book Value₹397
Face Value₹1.00
High / Low₹2,707/1,910
Market Cap₹1,02,596Cr.
Current Price₹2,484
Dividend Yield0.04%
Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and several consumer healthcare products.[1]
Quarterly Results
Yearly Results
Shareholding Pattern
Shareholding Trend
Balance Sheet
Cash Flows
Last updated at: 19 July 2026 at 17:13:36